The combination of two experienced global business support system (BSS) industry players forms a top-tier global team and delivers scalable full-stack solutions to empower growth and innovation for CSPsTORONTO, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Optiva (TSX:OPT) a leader in cloud-native charging and agentic AI BSS capabilities, today announced that it has entered into a strategic transaction with Qvantel, a global leader in digital BSS. The combination brings significant scale and financial strength, enabli ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of even ...

TORONTO, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Further to its news release on July 18, 2025, Optiva Inc. (TSX: OPT) ("Optiva" or the "Company"), a leader in powering the telecom industry with cloud-native billing, charging and revenue management software on private and public clouds, today announced that it has entered into an amended support agreement dated September 3, 2025 with holders ("Noteholders") of approximately 85% of its outstanding principal amount of 9.75% senior secured PIK toggle notes due July ...

Core Insights - Digitel has renewed its multi-year partnership with Optiva, enhancing its capabilities to innovate and grow in the competitive Venezuelan mobile market [1][2][3] - The renewal allows Digitel to utilize Optiva's full-stack BSS platform, which includes charging, billing, and provisioning, to accelerate product launches and improve customer experiences [1][2] - Digitel currently serves over 7.2 million subscribers and is the first operator to offer 5G technology in Venezuela, leveraging its existing LTE infrastructure for enhanced services [2][4] Company Overview - Digitel is a mobile telephony operator in Venezuela, providing both prepaid and postpaid connectivity solutions tailored for individuals and businesses [4] - The company has a robust 4G LTE network and is expanding its 5G technology in select cities, offering services like VoLTE for high-definition voice calls [4] - Digitel's service portfolio includes international roaming, enterprise solutions, IoT connectivity, and personalized customer support, focusing on quality and efficiency [4] Optiva Overview - Optiva Inc. is a provider of cloud-native, AI-powered revenue management software for the telecommunications sector, helping service providers capitalize on digital and 5G opportunities [5] - Established in 1999 and listed on the Toronto Stock Exchange, Optiva delivers its solutions globally on both private and public cloud platforms [5]

Summary of Opthea Limited (OPT) Corporate Update Webcast Company Overview - **Company**: Opthea Limited (OPT) - **Date of Update**: August 19, 2025 - **Context**: The call discusses the results of phase three clinical trials and the company's future direction following disappointing trial outcomes. Key Points Industry and Clinical Trials - **Phase Three Trials**: The company conducted two pivotal trials, COAST and SHORE, comparing its drug sosinibrocept with existing treatments aflibercept (Eylea) and Lucentis [6][10] - **Primary Endpoint Failure**: Both trials did not meet their primary endpoint of demonstrating superior visual acuity improvement at week 52 compared to the control arms [21][22] - **Patient Population**: Approximately 300 patients were enrolled per arm, with baseline characteristics well balanced across different treatment groups [12][13] - **Results**: The control arm showed a 13.75 letter improvement, while the combination therapy with sosinibrocept did not show statistically significant improvement [14][20] - **Safety Profile**: Sosinibrocept was well tolerated, with similar adverse event rates compared to aflibercept and Lucentis, although there was a slight trend for increased inflammation with higher doses of sosinibrocept [18][22] Financial and Development Funding Agreement (DFA) - **DFA Overview**: In August 2022, the company entered a DFA with OSCELET, initially securing $120 million, later amended to a total of $170 million [24][25] - **Settlement with Investors**: Following negative trial results, the company negotiated a settlement with DFA investors, paying $20 million in cash and providing a 9.99% equity stake, terminating the DFA [27][28] - **Current Cash Position**: As of the update, the company has approximately $20 million in cash on hand and no debt [28][32] Future Strategy and Governance - **Streamlining Operations**: The company has reduced its workforce by over 80% and the board of directors by 50% to align with its current scale [26][33] - **Strategic Review**: A comprehensive strategic review will be undertaken over the next several months to assess internal capabilities and potential partnerships [36][62] - **Focus on Shareholder Return**: The board emphasizes maximizing shareholder return as a primary objective in future decisions [36][64] Additional Insights - **Clinical Trial Insights**: The duration of the trials and patient selection may have impacted outcomes, with suggestions that the phase 2b trial's shorter duration might not have fully informed the phase 3 results [43][44] - **Future Opportunities**: The company is exploring potential therapeutic areas beyond ophthalmology, leveraging its scientific knowledge and assets [48][50] - **R&D Tax Credit**: The company plans to submit for an R&D tax credit, which has not yet been received [55] Conclusion - **Outlook**: The company is positioned to navigate its challenges with a focus on governance, operational efficiency, and strategic partnerships, aiming to enhance shareholder value moving forward [36][39][74]

CORPORATE UPDATE INVESTOR CALL – 20 August 2025 Dr Jeremy Levin – Chairman of the Board Fred Guerard – Chief Executive Officer Tom Reilly – Chief Financial Officer For personal use only Important Information This investor presentation (Presentation) is dated August 19th, 2025 and has been prepared by Opthea Limited (ASX:OTP) (Opthea or the Company). SUMMARY INFORMATION This Presentation is for information purposes only and is not a prospectus, disclosure document, product disclosure statement or other offer ...

Core Viewpoint - Opthea Limited has successfully settled the Development Funding Agreement (DFA) with its investors, ensuring the company's solvency and allowing it to continue operations after significant management changes and workforce reductions [1][6][7]. Group 1: DFA Settlement Details - The DFA was terminated following the failure to meet primary endpoints in the COAST and ShORe phase 3 clinical trials, leading to a mutual agreement with the DFA Investors [2][4]. - The settlement includes a one-time cash payment of USD20 million to the DFA Investors and the issuance of equity equivalent to 9.99% of the total issued share capital, amounting to 136,661,003 fully paid ordinary shares [4][6]. - The DFA Investors will enter a voluntary 12-month escrow period for the newly issued shares, with specific exceptions for legal requirements and certain corporate actions [4][5]. Group 2: Management Changes - Dr. Fred Guerard, the outgoing CEO, will step down on September 1, 2025, along with CFO Tom Reilly and Director Sujal Shah, who will leave on September 15, 2025 [1][7]. - Dr. Jeremy Levin will continue as Chairman and take on additional responsibilities as CEO starting September 1, 2025, overseeing the company's strategic direction [1][8]. Group 3: Financial Position and Future Strategy - Following the settlement, Opthea is expected to maintain approximately USD20 million in cash and cash equivalents, ensuring its ability to operate as a going concern [6]. - The company has reduced its workforce by over 80% and cut its Board of Directors by over 50% as part of a strategy to streamline operations [7]. - The Board will focus on maximizing shareholder value and may consider strategic partnerships, internal development, and potential capital returns to shareholders [11].

Core Insights - Optiva Inc. reported its second quarter financial results for the period ending June 30, 2025, highlighting continued growth in bookings and customer acquisition [2][3]. Financial Performance - Revenue for Q2 2025 was $10.3 million, a decrease from $11.4 million in Q2 2024 [11][14]. - Total Contract Value (TCV) bookings for Q2 2025 reached $26.6 million, with a trailing twelve months TCV of $64.3 million [8][9]. - The gross margin for Q2 2025 was 49%, down from 56% in the same period last year, primarily due to lower high-margin support and subscription revenue [14]. - The adjusted EBITDA loss for Q2 2025 was $1.6 million, slightly improved from a loss of $1.7 million in Q2 2024 [11][14]. - The net loss for Q2 2025 was $4.4 million, compared to a net loss of $5.6 million in Q2 2024 [11][14]. Customer Acquisition and Strategic Developments - Optiva secured two new customers in Q2 2025, including a Tier 1 European mobile virtual network operator (MVNO) and a Tier 1 European telecom, bringing the total new customers to 13 over the past two years [3][9]. - A key existing customer, Digitel, renewed its BSS platform support agreement for an additional three years [9]. - Optiva was recognized as a finalist for the Most Innovative Telco AI/ML Product or Solution for the Leading Lights 2025 Awards [10]. Cash Position and Operational Updates - The company ended Q2 2025 with approximately $12.9 million in cash, sufficient to meet working capital commitments for the foreseeable future [5][14]. - Optiva has entered into a 45-day support agreement with 85% of noteholders to negotiate a strategic transaction, with expectations of reaching a binding agreement before the end of the forbearance period [4][19].

Core Viewpoint - Optiva Inc. has entered into a Support Agreement with holders of approximately 85% of its outstanding 9.75% senior secured PIK toggle notes, allowing for a 45-day grace period to negotiate a Potential Transaction [1][2]. Group 1: Support Agreement and Grace Period - The Support Agreement provides a 45-day grace period for Optiva's special committee to negotiate with Noteholders and potential merger partners [2]. - During this grace period, Noteholders have agreed to forbear from exercising their rights related to any payment default on the Notes due July 20, 2025 [2]. Group 2: Financial Position and Operations - Optiva has approximately $12 million in cash as of July 13, 2025, ensuring business continuity and the ability to meet financial commitments [3]. - The company will continue to operate normally, fulfilling commitments to customers, employees, and suppliers during this period [10]. Group 3: Potential Transaction Details - The Potential Transaction involves exchanging the outstanding principal amount of the Notes and accrued interest for a combination of shares and new notes, along with a merger with a strategic third party [4][10]. - Common shareholders of Optiva are expected to receive nominal consideration for their shares in connection with the Potential Transaction [4][10]. Group 4: Repayment and Financial Obligations - The repayment of approximately $108.6 million in principal and $5.2 million in accrued interest due on July 20, 2025, will be addressed as part of the Potential Transaction if reached within the grace period [5]. Group 5: Regulatory and Approval Requirements - Completion of any Potential Transaction will require approval from Optiva's securityholders, court approvals if structured as a plan of arrangement, Toronto Stock Exchange approval, and necessary regulatory approvals [7].

Group 1 - Optiva Inc. announced the election of six new members to its board of directors during the annual meeting of common shareholders [1] - The elected directors include Patrick DiPietro, Lee Matheson, Simon Parmar, Robert Stabile, Barry Symons, and Birgit Troy, with voting results showing a high approval rate ranging from 96.35% to 96.42% [2] - KPMG LLP was re-appointed as the auditor of the Company, with the board authorized to determine the auditor's remuneration [3] Group 2 - Optiva Inc. is a leading provider of cloud-native, AI-powered revenue management software for the telecommunications industry, established in 1999 and listed on the Toronto Stock Exchange [5]